- Media Sphera
- Publishers
Applied research, peer-reviewed journal established in 2012. The journal is dedicated to practical oncology, management of anti-cancer campaign, prevention of oncological diseases.
Language of publication: Russian. English version of the most interesting articles is marked as En-version and available in free access in PDF.
Applied research, peer-reviewed journal established in 2012.
P.A. Herzen Journal of Oncology (Onkologiya. Zhurnal imeni P.A. Gertsena) bears the name of the outstanding russain surgeon oncologist, who first developed an operation on the plasty of the esophagus of the small intestine, which has received worldwide recognition.
The journal has a scientific and practical orientation. Specialists from related institutions are invited to discuss the publication of experimental research results.
The main composition of the editorial board of the journal is well-known oncology accountants working in the institute, which bears his name.
P.A. Hertzen Moscow Oncology Research Institute is the leading research institute of the Russian Ministry of Health on the problem of oncology.
P.A. Herzen Institute of Oncology is the oldest cancer research institution in Europe, founded in 1898 (by the merchants Morozovs). On the basis of the institute for the first time there was created the chancellor register of Russia (Associate Professor B.V. Milanov) and by the order of the People's Commissariat for Health Care of Russia the institute was called "Central Cancer Institute of the Russian Federation".
Director of the Institute Kaprin Andrey Dmitrievich, academician of the Russian Academy of Sciences is a famous scientist oncologist, member of the Presidium of the Russian Academy of Sciences, chief oncologist of the Russian Ministry of Health is the chief editor of the journal.
Deputy Editor-in-Chief Professor Alexeyev Boris Yakovlevich is a member of the governing bodies of the World Health Organization (WHA).
Professor Yevgeny Khmelevsky, chief radio therapist of the Russian Ministry of Health, Professor Valery Starinsky, chief oncologist of the Central Federal District of Russia.
The members of the editorial board are well-known Russian oncologists – Academician of the Russian Academy of Sciences Reshetov I.V. (reconstructive-plastic surgery), Academician of the Russian Academy of Sciences Solodkiy V.A. (radiology, radiation therapy), Academician of the Russian Academy of Sciences Stilidi I.S. (onco-surgery, thoracic, abdominal surgery), Academician of the Russian Academy of Sciences Chojnzonov E.C. (radiology, radiation therapy). (head and neck tumors).
Thus, the scientific articles of the journal cover the issues of diagnostics, combined and complex treatment of malignant tumors of all localizations. All articles published in the journal in the sections "original", "work experience" of practical institutions (oncological dispensaries), "reviews of scientific research" on topical issues of oncology are subject to a closed review and are discussed at the general meeting of the editorial board. Publication is done with a positive review. If necessary, a double review is conducted.
The journal has a discussion section on controversial issues in clinical oncology.
The authors of the published articles are both well-known oncology scientists and doctors of large oncology dispensaries, on the basis of which the departments of oncology work (in the section experience of practical institutions. These are doctors of Barnaul, Tomsk, Khabarovsk, Khanty-Mansiysk, Kazan, Irkutsk, Ryazan, Rostov and others.
The journal is dedicated to practical oncology, management of anti-cancer campaign, prevention of oncological diseases.
All manuscripts submitted for publication are obligatory reviewed.
"Onkologiya. Zhurnal imeni P.A. Gertsena" is included into following international data bases and information and reference publications: RISC (Russian Index of Science Citation), Scopus, Ulrich's Periodicals Directory, Google Scholar.
The journal is included into the list of peer-reviewed science press, recommended for publication of results of dissertations for academic degrees and titles.
1. Russian Index of Science Citation
2. Scopus CiteScore
3. SJR (Scimago Journal & Country Rank)
Solving all issues through the electronic edition service
Additional services in preparing of articles for publishing
Consultations about publishing ethics
Andrey D. Kaprin
Editor-in-Chief, Corr. Member of the RAS, Prof., MD, PhD, Director General, National Medical Research Radiological Center of the MInistry of Health of the Russian Federation (Obninsk, Russia)
Boris Ya. Alekseev
Deputy Editor-in-Chief, Prof., MD, PhD, Deputy General Director for Science, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia)
Valeriy V. Starinskiy
Deputy Editor-in-Chief, Prof., MD, PhD, Deputy Director General for Science, P. Hertsen Moscow Oncology Research Institute - Branch of the National Medical Research Radiological Centre of the Ministry of the Russian Federation (Moscow, Russia)
Valery I. Chissov
Deputy Editor-in-Chief, Corr. Member of the RAS, Prof., MD, PhD, Advisor to the Director, Р. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia)
Anatoly S. Mamontov
Executive Secretary, Prof., MD, PhD, Leading Researcher Research and Education Branch, Р. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia)
Igor V. Reshetov
Executive Secretary, Prof., Acad. of the RAS, MD, PhD, Director, Educational and Research Director, Educational and Research Clinical Center for Plastic Surgery, I.M. Sechenov First University (Moscow, Russia)
Aleksei M. Beliaev
Member of the Editorial Board, Prof., MD, PhD, Director, Federal State Budget Institution «Petrov Research Institute of Oncology» Ministry of Healthcare of the Russian Federation (St. Petersburg, Russia)
Anna V. Boiko
Member of the Editorial Board, Prof., MD, PhD, Head of Department radiotherapy with modification, Moscow Herzen Research Oncological Institute (Moscow, Russia)
Vasily I. Borisov
Member of the Editorial Board, Prof., MD, PhD, Сhief department, Clinical Oncology Dispensary № 1 (Moscow, Russia)
Oleg I. Kit
Member of the Editorial Board, Acad. of the RAS, Prof., MD, PhD, National Medical Research Center for Oncology (Rostov-on-Don)
Sergey A. Krasnyy
Member of the Editorial Board, Prof., Acad. of the NAS of Belarus, MD, PhD, Deputy Director for Scientific Work, N.N. Aleksandrov Republican Scientific and Practical Center for Oncology and Medical Radiology (Lesnoy, Belarus)
Ivan P. Moshurov
Member of the Editorial Board, Assoc. Prof., MD, PhD, Chief physician, Voronezh Regional Clinical Oncology Dispensary, Head of the Department, N.N. Burdenko Voronezh State Medical University (Voronezh, Russia)
Elena R. Nemtsova
Member of the Editorial Board, PhD, Department of Experimental Pharmacology and Toxicology P. A. Herzen Moscow Research Cancer Institute (Moscow, Russia)
Elena G. Novikova
Member of the Editorial Board, Prof., MD, PhD, Head of the gynecological department, Р. Hertsen Moscow Oncology Research Institute - branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation (Moscow, Russia)
Andrey E. Orlov
Member of the Editorial Board, Assoc. Prof., MD, PhD, Department of Quality Management in Healthcare, Institute for Professional Education, Samara State Medical University (Samara, Russia)
Sergey L. Polyakov
Member of the Editorial Board, MD, PhD, Chief Freelance Oncologist, Ministry of Health of the Republic of Belarus, Director, N.N. Aleksandrov Republican Scientific and Practical Center of Oncology and Medical Radiology (Lesnoy, Belarus)
Natalia S. Sergeeva
Member of the Editorial Board, Prof., D.Bi.Sci., Department head, Р. Hertsen Moscow Oncology Research Institute (Moscow, Russian Federation)
Vladimir A. Solodky
Member of the Editorial Board, Prof., Acad. RAS, MD, PhD, Director, Russian Scientific Center of Roentgenoradiology of the Ministry of Healthcare of the Russian Federation (Moscow, Russia)
Georgy A. Frank
Member of the Editorial Board, Prof., acad. of RAS, MD, PhD, Head of the Department of Pathological Anatomy, Russian Medical Academy of Continuing Professional Education (Moscow, Russia)
Rustem Sh. Khasanov
Member of the Editorial Board, Corr. Member of the RAS, Prof., MD, PhD, Rector, Kazan State Medical Academy (Kazan, Russia)
Evgeny V. Khmelevsky
Member of the Editorial Board, Prof., MD, PhD, Head of department of radiotherapy, P.A. Herzen Research Oncology Institute (Moscow, Russia)
Evgeny L. Choinzonov
Member of the Editorial Board, Prof., acad. of RAS, MD, PhD, Director, Tomsk National Research Medical Сепtеr, Russian Academy of Sciences (Tomsk, Russia)
Vladimir D. Chkhikvadze
Member ot the Editorial Board, Prof., MD, PhD, Head of Surgical Clinic, Honored Physician of the Russian Federation, Surgical Oncologist of the Russian Scientific Center of Roentgenoradiology (Moscow, Russia)
Yury A. Shelygin
Member of the Editorial Board, Acad. of the RAS, Prof., MD, PhD, Director, State Scientific Centre of Coloproctology (Moscow, Russia)
Sergey A. Shinkarev
Member of the Editorial Board, MD, PhD, Chief physician, Lipetsk Regional Oncological Dispensary (Lipetsk, Russia)
Kásler Miklós
Member of the Editorial Board, Prof., MD, Ph.D., DSc., dr.h.c. FRCS - Orszagos Onkologiai Intezet Budapest (Budapest, Hungary)
Christoph Zielinski
Member of the Editorial Board, Prof., MD, PhD, Medizinische Universitat Wien, Department of Medicine (Vienna, Austria)
Nur Olgun
Member of the Editorial Board, Prof., MD, PhD, Dokuz Eylul Universitesi Tip Fakultesi, Department of Pediatric Oncology (Izmir, Turkey)
John J. Welch
Member of the Editorial Board, MD, PhD, Senior Investigator, National Cancer Institute, Center for Global Health (Bethesda, USA)
Rafael Molina
Member of the Editorial Board, MD, PhD, Senior Consultant, Laboratory of Biochemistry, Hospital Clinic Barcelona (Barcelona, Spain)
Edvard L. Trimble
Member of the Editorial Board, MD, PhD, Director, Center for Global Health National Cancer Institute (Bethesda, USA)
Salim Nidal
Member of the Editorial Board, Prof., MD, PhD, Radiotherapist, oncologist, Head of the Radiotherapy Center (Israel)
Martin Flür
Member of the Editorial Board, MD, PhD, Senior Physician, Hospital Gemeinschaftskrankenhaus Herdecke, member of Society of Palliative Medicine) (Herdecke, Germany)
Giovanni Apolone
Member of the Editorial Board, MD, PhD, Scientific Director, Fondazione IRCCS Istituto Nazionale dei Tumori (Italy)
Claudio Lombardo
Member of the Editorial Board, Prof., MD, PhD, Director, Organisation of the European Cancer Institutes (Italy)
Radan R. Džodić
Member of the Editorial Board, Prof., MD, PhD, General director, Institute for Oncology and Radiology of Serbia, surgeon, oncologist (Serbia)
There is no fee for the publication of manuscripts.
By submitting an article to the publisher, the author agrees to the terms of the CONTRACT OFFER.
When preparing a manuscript, authors should follow Recommendations on conducting, describing, editing and publishing the results of scientific work in medical journals of the International Committee of Medical Journal Editors (ICMJE).
When reviewing an article, the editorial board can check the material using Anti-plagiarism system. If multiple borrowings are found, the editorial board acts according to the rules COPE.
In preparing the manuscript, authors should follow the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors.
The Editorial Board can check the material using the Anti-Plagiarism system. In the case of multiple borrowings, the Editorial Board operates in accordance with COPE rules.
Guidelines for preparing and submitting manuscripts to the "P.A. Herzen Journal of Oncology" journal
"P.A. Herzen Journal of Oncology" is included in the list of top Russian peer-reviewed journals, recommended by the Higher Attestation Commission of the Ministry of Education and Science of the Russian Federation for publishing results of scientific research in the course of thesis preparation. The journal is represented in international information systems and databases and in accordance with their requirements the authors should comply with the following rules.
1. EDITORIAL ETHICS AND CONFLICT OF INTERESTS
Submitted manuscripts should be signed by the head of the host organization. An official referral should also be provided (download a blank form of the referral - MS Word.doc), specifying if the article is a part of the author's thesis.
Manuscripts are to be signed by all authors.
One cannot submit a paper previously accepted or published elsewhere.
Authors are responsible for disclosing financial or other potential conflict of interests that might bias or be seen to bias their work.
The authors are required to indicate the role of sponsors or funders in each of the following: study design, collection and analysis of data, and making the decision to publish the results. If neither the sponsor, nor the funder played such a role, this should be stated in the referral (see above).
Informed consent
It is prohibited to publish patient-identifiable information, i.e. his/her name, initials, or case number on photographs or in illness descriptions and family trees, except for the cases of paramount scientific interest and an informed consent given by the patient or his (her) parents or guardians. Obtaining the informed consent should be stated in the article.
Human rights and animal rights
For experiments involving human subjects the authors should specify whether they conform to the local or regional ethical standards as well as to the ethical standards accepted by the 1975 Helsinki Declaration and also the 2000 revised version.
For experiments involving laboratory animals the authors should specify whether they conform to the husbandry conditions accepted by the host organization, recommendations of the national research council, and national legislation.
The author is responsible for the accuracy of bibliographic data.
2. The editors retain the customary right to shorten and alter submitted manuscripts. A manuscript is considered registered on the date its final variant (revised in accordance with the recommendations of the Editorial Staff or the reviewer) is received.
3. No publication fee is charged.
4. SUBMISSIONS are done online through http://www.cochrane.ru. Registration is required.
We inform you that the journal certifies reviews of its reviewers on the Publons.
You can download and read the instruction for using under the link - Instruction.
Media Sphera Publishing House is a partner of Publons: https://publons.com/community/our-partners/. Publons partners with the world's publishers and leading industry organizations to recognize the contributions of expert reviewers and editors.
To submit a manuscript, please, prepare the following:
5. FIGURES
Each figure should be attached as a separate TIFF, JPEG or PNG image. As to figures that were created or processed using Microsoft Office tools (WORD or POWER POINT), they should be attached as separate files with corresponding extensions (.doc, .docx, .ppt). File names should be given according to figure numbers in the text (e.g., Fig-1, Fig-2a, Fig-2, etc.). Our online submission and editorial system requires that all your images were downloaded as a single .zip or .rar archive.
Captions for figures and photos should be grouped together at the end of the article. General descriptions and the key to abbreviations should be provided. Graph legends should explain the designation of axes and units of measurements. Micrograph captions should indicate the staining method and magnification.
We insist that you send only high-quality images. Please, make sure of high image resolution and large enough letters typed in the images (remember that they should be easy to read when printed).
Captions for figures and photos, notes must be in Russian and English.
6. TEXT
Articles should be typed in Times New Roman or Arial (14 pt size, 1.5 spaced, left margin set at 3 cm, other margins - 2 cm). Pages should be enumerated. Automatic hyphenation is not allowed.
An article SHOULD NOT EXCEED 18 pages (including illustrations, tables, an abstract and references), review or advisory letter – 3 pages.
The TITLE PAGE should bear: 1) title of the article; 2) author's surname and initials; 3) complete name of the author's place of work in the nominative case with obligatory indication of its status (an abbreviation before the name) and affiliation; 4) postal code and full address of the organization, country, city.
In case of multiple authorship a numerical footnote should be applied to each author's surname indicating his/her place of work. If all authors work in the same organization it is not necessary to cite their place of work for each of them.
This information should be presented in both Russian and English. It is recommended that the authors’ surnames are spelled as in their previous publications or transliterated in accordance with the BSI standards (British Standards Institution), see http://ru.translit.net/?account=bsi. As to organizations, the official English name should be provided.
A separate page should contain additional information on each of the authors as required by the Russian Science Citation Index: surname, first and patronymic names in Russian and transliterated, e-mail and postal address of the organization for correspondence with the authors (can be one for all authors). For better correspondence, please, provide contacts of one of the authors, including e-mail and mobile phone number. Also you must specify the ORCID for the author who submits the article, and preferably for each author of the article. If there is no ORCID number, you need to obtain it by registering at https://orcid.org/. We recommend to check the correct spelling of the institution's name on the site https://grid.ac.
The COMPOSITION of an original article should be the following: an abstract and key words (in both Russian and English), short introduction describing the current state of the problem, aim, material and methods, results and discussion, enumerated findings or conclusion, references.
The article should be brief and clear. It should not contain long historical reviews or reiterations.
The manuscript can be supplemented by a glossary (for unobvious terminology).
Besides generally accepted abbreviations and acronyms of units of measurement as well as physical, chemical, and mathematical quantities and terms (e.g. DNA), one can introduce abbreviations of own expressions frequently used in the article. All abbreviations introduced by the author are to be expanded at first mention. Simple words must not be contracted, even if they are often repeated in the text.
Drug doses, units of measurement, and other numerical values should be provided in accordance with the International System of Units (SI).
7. AUTHOR'S SUMMARY (ABSTRACT)
An abstract is the basic information source for Russian and foreign information systems and databases. Despite its necessary brevity, an abstract, like a business card, is meant to be exhaustive. Judging from the abstract, the editor decides whether or not the article is worth reviewing. After the article is published, most potential readers (up to 95% by some estimates) will not read beyond the abstract. Thus, it should be able to explain the essence of the study to the reader and entice him/her into obtaining a copy of the full paper for more details. The size of the abstract depends on the amount of information in the article, its scientific value and/or practical importance, however, has to lie within the range of 200-250 words.
Structured abstract
A structured abstract is an essential part of any scientific article that contains experimental or quasi-experimental results, empirical evidence, or systematic review. Its informative value is usually higher than that of an ordinary unstructured abstract. It may be also easier to read and remember. Moreover, a structured abstract ensures higher visibility of the article in international databases, which ultimately influences its citation potential.
A structured abstract should include five sections in chronological order: Rationale, Aim, Methods, Results, and Discussion.
RATIONALE – a brief (1-3 sentences) description of the problem that necessitated the study. The problem can be characterized by its scale, mediated effects, and/or lack of scientific knowledge.
AIM – this section is to define the primary aim, or the main question of the study. Please, note that the aim should be as concrete as possible without boiling down to overall comparisons.
METHODS – this section is meant to provide the following information: 1) subject details (like whether the participants were diseased or healthy), 2) control group details if any, 3) inclusion criteria, 4) performed interventions, 5) study site and 6) duration, 7) outcomes (including measures that can be taken to determine their correspondence with the primary aim) and 8) evaluation methods. The necessity of specifying statistical tests and software will be addressed individually by the editor.
RESULTS – this section should provide further details on study participants (such as the number of those enrolled and those who completed the study as well as some major characteristics of the latter) and evaluate the outcomes that correspond with the primary aim. It is possible to present the results from 2-3 subgroups divided by age, sex, clinical features, etc. Adverse effects, if any, must be reported. Statistical measures (p value) should be given with an accuracy of three decimal places. When investigating multi-criteria relationships (e.g. one dependant and several independent variables), please, provide the results of multifactorial analyses.
CONCLUSION – a summary of study results that correspond with its primary aim (1-3 sentences). Authors are advised to avoid excessive generalization and balance their appraisal of positive and negative effects of an intervention.
A structured abstract should not exceed 250 words. Appropriateness of a larger abstract is discussed individually.
Commercial names of medical products are not allowed in the abstract.
Randomized trial
When reporting the results of a randomized trial, the CONSORT Statement should be complied with. Thus, an abstract is to include the following sections:
- study DESIGN
- METHODS
participants
interventions
objectives or study hypotheses
outcomes
randomization sequence generation
blinding (masking) (if applicable)
- RESULTS
number of randomized participants
numbers analyzed
outcomes and estimation (at the primary endpoint)
adverse events
- CONCLUSION
- study number (registration number; e.g. at clinicaltrials.com)
- funding source
Systematic review
Abstracts of systematic reviews should follow PRISMA recommendations (for reviewing randomized trials) and include the following sections:
- AIM or OBJECTIVES
- METHODS
inclusion criteria
data sources
study eligibility criteria
- RESULTS
review of relevant studies
synthesis of results
effect and sensitivity analysis
- DISCUSSION
summary of evidence and analysis (consistency, accuracy, generalizability, risk of bias)
interpretation of results
- funding source
- study number (registration number; e.g. at clinicaltrials.com)
Unstructured abstract
Non-systemic reviews, case reports, and opinion articles usually have unstructured abstracts. Narrative logic should, however, remain: one proceeds from presenting the problem to suggesting a solution and describing own results. Unstructured abstracts should not exceed 150 words.
Keywords should reflect the topic of the article. One can use some particular terms from the text, key terms in the field, or other relevant expressions able to improve search results. It is not recommended to repeat words from the title.
8. TABLES DESIGN. All tables should be enumerated and named. Clipped words are not allowed. Data in the table must be coincident with corresponding data in the text and treated statistically. The tables may be given either in the text, or on separate pages.
Signatures and all text data must be sent in Russian and English!
9. REFERENCE LISTS are to be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals of the International Committee of Medical Journals Editors (ICMJE). Reference accuracy guarantees that the citations will be taken into account when assessing scientific public activity of the corresponding authors and their host organizations.
The maximum number of references for original articles is 30, literature reviews - 60, lectures and other materials – 15. Besides fundamental works, the list should include relevant publications over the last 5 years.
References should be numbered and ordered sequentially as they appear in the text.
In-text reference numbers should be in square brackets.
References to unpublished works are not allowed.
According to new reference guidelines that consider requirements of Web of Science and Scopus indices, bibliographic descriptions for Non-Latin References should be provided in not only their source languages, but also in Latin.
Thus, in order to be included in citation indices and DOI-CrossRef system, reference lists should be displayed as described below.
For example:
Литература/References
1. Медведев Б.И., Сюндюкова Е.Г., Сашенков С.Л. Плацентарная экспрессия эритропоэтина при преэклампсии. Российский вестник акушера-гинеколога. 2015;15:1:4-8. [Medvedev BI, Syundyukova EG, Sashenkov SL. Placental expression of erythropoietin in preeclampsia. Rossiiskii vestnik akushera-ginekologa. 2015;15:1:4-8. (In Russ.).] https://doi.org/10.17116/rosakush20151514-8
2. Matsumoto K, Nakamaru M, Obara H, Hayashi S, Harada H, Kitajima M, Shirasugi N, Nouga K. Surgical Strategy for Abdominal Aortic Aneurysm with Concurrent Symptomatic Malignancy. World Journal of Surgery. 1999;23(3):248-251. https://doi.org/10.1007/pl00013189
When referencing a journal article, always include the DOI (Digital Object Identifier in the CrossRef system). DOI search should be done at http://search.crossref.org/ or https://www.citethisforme.com. To start the search, type in the English title of the article. The latter website is able to provide you with not only the DOI, but also a full bibliographic description in AMA style. One should keep in mind that most journal articles (including many Russian-language ones) published after 2013 are registered in the CrossRef system and have a DOI.
Preparing Russian-language references for importation into international citation indices.
1. Journal articles.
Authors’ surnames and initials as well as the English title of the article should be identical to those in the original publication. Journal name that follows should be transliterated according to the BSI standard (can be done automatically at http://ru.translit.net/?account=bsi). Then come publication details (year, volume, issue, and pages). Source language should be indicated in parentheses. At the end of the description, the DOI should be given (if available). For example:
... [Belaia Z, Rozhinskaia L, Mel'nichenko G, Sitkin I, Dzeranova L, Marova E, Vaks V, Vorontsov A, Il'in A, Kolesnikova G, Dedov I. The role of prolactin gradient and normalized ACTH/prolactin ratio in the improvement of sensitivity and specificity of selective blood sampling from inferior petrosal sinuses for differential diagnostics of ACTH-dependent hypercorticism. Problemy endokrinologii. 2013;59(4):3-10. (In Russ.).] https://doi.org/10.14341/probl20135943-10
One should not cite journal articles that have no English title.
Citations from theses, theses abstracts, conference proceedings, etc. are not allowed.
2. All other sources should be transliterated according to the BSI standards but preserving their original stylesheets. Source language should be indicated in parentheses at the end of the description. Example: Gilyarevskii S.R. Miokardity: sovremennye podkhody k diagnostike i lecheniyu. M.: Media Sfera; 2008. (In Russ.).
Footnote: If the source was translated into English, please, indicate the translation, and not transliteration.
Please pay attention! The only correct form of doi-link:
https://doi.org/10.5468/ogs.2016.59.1.1
Do not use «doi:», «dx.doi.org», etc. Within the link only hyphen is used.
There is no dot after doi and URL!
For all your bibliographic entries, regardless the source language, please, apply the AMA Reference Style (http://www.amamanualofstyle.com).
Sample bibliographic entries:
Source type |
Russian-language material |
Non-Russian language material |
Regular journal article |
Белая Ж.Е., Рожинская Л.Я., Мельниченко Г.А., Ситкин И.И., Дзеранова Л.К., Марова Е.И., Вакс В.В., Воронцов А.В., Ильин А.В., Колесникова Г.С., Дедов И.И. Роль градиента пролактина и АКТГ/пролактин-нормализованного отношения для повышения чувствительности и специфичности селективного забора крови из нижних каменистых синусов для дифференциальной диагностики АКТГ-зависимого гиперкортицизма. Проблемы эндокринологии. 2013;59(4):3-10. [...] https://doi.org/10.14341/probl20135943-10 |
Vega K. Heart Transplantation Is Associated with an Increased Risk for Pancreaticobiliary Disease. Annals of Internal Medicine. 1996;124(11):980. https://doi.org/10.7326/0003-4819-124-11-199606010... |
Journal article within an appendix |
Самсонов С.Н., Петрова П.Г., Соколов В.Д., Стрекаловская А.А., Макаров Г.А., Иванов К.И. Гелиогеофизическая возмущенность и обострения сердечно-сосудистых заболеваний. Журнал неврологии и психиатрии им. С.С. Корсакова. 2005;(14)(прил. Инсульт):18-22.[...] |
Crinò L, Cappuzzo F. Present and future treatment of advanced non–small cell lung cancer. Seminars in Oncology. 2002;29(3)(suppl 9):9-16. https://doi.org/10.1053/sonc.2002.34266 |
Book (authors) |
Гиляревский С.Р. Миокардиты: современные подходы к диагностике и лечению. М.: Медиа Сфера; 2008.[...] |
Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers; 1996. |
Book (edited) |
Whole book: |
Whole book: |
Legal documents (draft laws, codes, resolutions, warrants, federal standards, rules) |
Федеральный закон Российской Федерации №323-Ф3 от 21 ноября 2011 г. «Об основах охраны здоровья граждан Российской Федерации». Ссылка активна на 12.12.2014. [...] http://www.rosminzdrav.ru/documents/7025-federalnyy-zakon-323-fz-ot-21-noyabrya-2011-g |
|
Patents |
Патент РФ на изобретение №2193864/ 10.12.02. Бюл. №34. Газазян М.Г., Пономарева Н.А., Иванова О.Ю. Способ ранней диагностики вторичной плацентарной недостаточности. Ссылка активна на 12.12.2014. [...] http://www.ntpo.com/patents_medicine/medicine_1/medicine_432.shtml |
Rabiner RA, Hare BA, inventors; OmniSonics Medical Technologies Inc, assignee. Apparatus for removing plaque from blood vessels using ultrasonic energy. US patent 6,866,670. March 15, 2005. |
Media and online materials |
Протокол исследования больных с нарушениями сна [архив]. Ссылка активна на 12.12.2014. [...] http://sleepmed.ru/protissl.zip |
Hormone replacement therapy [audio]. National Public Radio. August 5, 2002. Accessed March 4, 2004. http://www.npr.org/templates/story/story.php?storyId=1147833 |
Electronic journal article |
Полуэктов М.Г. Первичные и вторичные инсомнии и расстройства дыхания во сне. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011;111(9)(2):10-18. Ссылка активна на 12.12.2014. [...] http://www.mediasphera.ru/journals/korsakov/detail/782/12404/ |
Duchin JS. Can preparedness for biological terrorism save us from pertussis? Arch Pediatr Adolesc Med. 2004;158(2):106-107. Accessed June 1, 2004. http://archpedi.ama-assn.org/cgi/content/full/158/2/106 |
10. For original articles with multiple authors please indicate on a separate page each author’s contribution to:
- study concept and design,
- data collecting and handling,
- statistical data analysis,
- writing,
- editing.
Example:
Authors: A.S. Ivanov, N.T. Petrov, K.I. Sidorov
Author’s contribution:
Study concept and design - A.I., K.S
Data collecting and handling - N.P.
Statistical data analysis - N.P
Text writing - K.S.
Editing - A.I
The Editorial Office can be contacted as follows:
tel: +7(495)945-8655, e-mail: herzen-onkol@mail.ru
Managing editor I. N. Sokolova
Double-blind peer review: the peer reviewers not know the names of the authors, and the authors do not know who reviewed their manuscript.
Responsibilities of a Reviewer:
The World Association of Medical Editors (http://www.wame.org) has educational materials online for editors, and these include a list of reviewer responsibilities: http://wame.org/syllabus-for-prospective-and-newly-appointed-editors
The role and responsibilities of the reviewer can also be found in CSE’s White Paper on Promoting Integrity in Scientific Journal Publications: https://www.councilscienceeditors.org/resource-library/editorial-policies/white-paper-on-publication-ethics/
All scientific articles for the journal “P.A. Herzen Journal of Oncology”, submitted in electronic or paper form, are subject to reviewing.
The Head of Editorial or/and Executive Secretary verifies the compliance of an article typography to the journal requirements within one week.
The Head Editor determines the compliance of an article to the journal specialization within two weeks and forwards this article for scientific review to an appropriate specialist - Doctor of Medical Sciences. A member of the Editorial Board or engaged specialist, competent in the subject of reviewing article and who has publications covering the subject of reviewing article during last three years, can be a reviewer.
It’s necessary to point the compliance of an article to its title, characterize its relevance and scientific level, strengths and weaknesses and evaluate the expediency for publication in review.
The review is given to the author or to The Higher Attestation Commission upon its request without the reviewer’s sign, last name, position and place of work.
If the reviewer recommends correcting or improving something in the article, the Head of Editorial sends the review text to the author in order to make appropriate changes in his article.
The editorial board of the journal sends the review to the authors. If the reviewer recommends any refinements, the editorial staff would suggest the author either make corrections or dispute them reasonably. When a revision is requested, the author must resubmit the revised manuscript within two months. The modified version of the article is re-sent for review.
If authors refuse to revise the manuscript, they should notify the editorial board verbally or write about the withdrawal of their manuscript from submission to publication. If authors fail to return the revised manuscript after three months from sending them the review, the editorial board takes the manuscript off the register and notifies the author accordingly.
Each manuscript will only be allowed three rounds of review and revisions. Authors are thus urged to address all issues raised by the reviewers after the first round of peer-review. If authors fail to do so after the third round, the editorial board takes the manuscript off the register and notifies the author accordingly.
Should irreconcilable differences in opinions between authors and reviewers arise, the editorial board will send the manuscript for additional review, or the editor-in-chief resolves the conflict at an editorial board meeting.
In case the article was rejected, the Editorial sends reasonable refusal to the author. It’s possible to make an additional review by another reviewer under the urging of the author.
The final decision about publication and its time limits is made by the Editorial Board by open voting. It’s possible to publish articles in some cases when it has positive reviews, by joint decision of the Head of Editorial Board and the Head Editor.
Following the decision to publish an article, the Head of Editorial informs an author indicating time limits of the article’s edition.
Manuscripts of reviews are retained in Editorial for 5 years.
Advertising and sponsorship are important to our journals in helping us to provide value for our users.
Our readers and customers expect us to be trustworthy and independent, so our advertising should support that expectation.
Media Sphere (including all of our journals published) accepts advertising for products and services that are mostly of an interest to users in their professional activities ( such as OTC & Rx drugs, medical equipment etc). Advertisements and sponsorship must be legal, truthful and comply with the relevant laws & regulations of the Russian Federation.
Our users should immediately be able to distinguish between advertising and editorial content.
Sponsored content should be clearly identifiable. The nature of any commercial relationship must be transparent to our users.
Our advertising policy does not allow advertising or sponsorship to influence editorial decisions.
Online advertising or sponsorship should not impede users’ access to editorial content.
We accept advertising and sponsorship from competitors.
We do not accept advertising of uncertified drugs and equipment.
We do not accept advertising or sponsorship relating to tobacco products, or to products and services from tobacco companies, and alcohol, as well as their related companies and funds.
Advertising and sponsorship are subject to publishers’ oversight.
If a proposal is refused for reasons outside these guidelines, Media Sphere will provide an explanation.
Buying the print version you get an access for electronic version of journal in your account.
The subscription price is for individuals.
For subscription fees and billing for legal entities, please send inquiries to: zakaz@mediasphera.ru
Please write the correct address when ordering the print version.
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.